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MSP1Plasmodium falciparum takes advantage of two broadly deﬁned alternate invasion pathways when infecting
human erythrocytes: one that depends on and the other that is independent of host sialic acid residues on the
erythrocyte surface. Within the sialic acid-dependent (SAD) and sialic acid-independent (SAID) invasion path-
ways, several alternate host receptors are used by P. falciparum based on its particular invasion phenotype. Ear-
lier, we reported that two putative extracellular regions of human erythrocyte band 3 termed 5C and 6A function
as host invasion receptor segments binding parasite proteins MSP1 and MSP9 via a SAID mechanism. In this
study, we developed two mono-speciﬁc anti-peptide chicken IgY antibodies to demonstrate that the 5C and
6A regions of band 3 are exposed on the surface of human erythrocytes. These antibodies inhibited erythrocyte
invasion by the P. falciparum 3D7 and 7G8 strains (SAID invasion phenotype), and the blocking effect was en-
hanced in sialic acid-depleted erythrocytes. In contrast, the IgY antibodies had only a marginal inhibitory effect
on FCR3 and Dd2 strains (SAD invasion phenotype). A direct biochemical interaction between erythrocyte
band 3 epitopes and parasite RhopH3, identiﬁed by the yeast two-hybrid screen, was established. RhopH3
formed a complexwith MSP119 and the 5ABC region of band 3, and a recombinant segment of RhopH3 inhibited
parasite invasion in human erythrocytes. Together, theseﬁndings provide evidence that erythrocyte band 3 func-
tions as a major host invasion receptor in the SAID invasion pathway by assembling a multi-protein complex
composed of parasite ligands RhopH3 and MSP1.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Red blood cell (RBC) invasion by malaria parasites involves complex
yet precisely timed events that require speciﬁc host–parasite interactions
[1,2]. In Plasmodium falciparum, two unique RBC invasion phenotypes
have been observed in the ﬁeld [3–5] and laboratory culture [6–9]: one
that largely relies on sialic acid residues of RBC sialoglycoproteins for in-
vasion (e.g., FCR3, Dd2, W2-mef, Camp, and FVO strains) and the other
which does not depend on RBC sialic acids (e.g., 3D7, 7G8, FCB-1, HB3,-dependent; SAID, sialic acid-
, glycophorin C;MSP1,merozo-
Neu, neuraminidase
ental, Molecular & Chemical
on Avenue, Room 714, Boston,
3568.and Thai-2 strains). These observations led to the recognition of two dis-
tinct RBC invasion pathways involving either a sialic acid-dependent
(SAD) or sialic acid-independent (SAID) mechanism. In the SAD invasion
pathway, RBC sialoglycoproteins such as glycophorins are known to serve
as major invasion receptors interacting with parasite ligands EBA-175
[10–14], EBL-1 [15,16], and EBA-140 (also known as BAEBL) [17–20]. In
addition, several hypothetical RBC sialoglycoproteins have been implicat-
ed as host invasion receptors associating with P. falciparum proteins such
as Rh1 and EBA-181 (also known as JESEBL) by a SADmechanism [14,21].
However, it is known that RBCs lacking glycophorins are invaded, albeit at
a reduced rate, by the ﬁeld isolates of P. falciparum indicating the exis-
tence of SAID invasion pathways.
In the SAID invasion pathway, the hypothetical RBC receptor X
interacting with an unidentiﬁed P. falciparum merozoite protein [22,
23] and the hypothetical receptor Z interacting with P. falciparum
Rh2b [24] have been proposed. RBC antigen Kx, modiﬁed by a trypsin-
like enzyme, is known to interactwith P. falciparumAMA-1 during inva-
sion by a SAID mechanism [25]. Similarly, the complement receptor 1
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way interacting with P. falciparum Rh4 [26,27]. Recently, erythrocyte
membrane protein Basigin has been identiﬁed as a host receptor
interactingwith P. falciparumRh5 [28]. Earlier, we reported that twopu-
tative exofacial regions of humanRBC band3 termed5ABC (amino acids
720–761) and 6A (amino acids 807–826) function as a non-glycosylated
invasion receptor binding to the 19 kDa and/or 42 kDa C-terminal pro-
cessing product(s) of P. falciparumMSP1 (termed MSP119 and MSP142,
respectively), a major GPI-anchored merozoite surface protein [29].
The invasion receptor activity was most noteworthy at the 5C (amino
acids 742–761, the C-terminal half of 5ABC) and 6A regions based on
the invasion blocking assay using the P. falciparum 3D7 strain [29]. Our
subsequent studies have shown that two regions of P. falciparum
MSP9 (also known as ABRA and p101) also interact directly with
the 5ABC region of band 3 [30], while forming a co-ligand complex
with MSP119 (or MSP142) [31]. Speciﬁc complex formation between
MSP1 and MSP9 was further supported by subsequent mapping of a
P. falciparum protein interaction network in which the MSP1–MSP9
interaction was central to a large cluster of invasion-related protein
interaction network [32].
Human RBC band 3 consisting of 911 amino acids is characterized by
an N-terminal cytoplasmic domain, C-terminal membrane-embedded
domain, and C-terminal cytoplasmic tail [33,34]. The N-terminal cyto-
plasmic domain provides an anchoring site for the RBC skeleton,
deoxyhemoglobin, glycolytic enzymes, and the protein tyrosine kinase
p72syk [35–37]. The C-terminal membrane-spanning domain catalyzes
the exchange of anions (Cl− for HCO3−) across the membrane to in-
crease the CO2 transport capacity in RBCs [38]. The relatively short C-
terminal cytoplasmic tail associates with carbonic anhydrase II required
for moving CO2 from tissues to the lung [39]. A high-resolution crystal
structure of the N-terminal cytoplasmic domain has been reported
[36], whereas several low-resolution three-dimensional maps of the
membrane-spanning domain of band 3 are also available [40]. Comput-
er generated topologymodels of human RBC band 3 predict the protein
spans the lipid bilayer 12–14 times giving rise to 6–7 extracellular do-
mains [41]. The topology of transmembrane (TM) segments TM1 to
TM9 (ending at Leu-724) is relativelywell deﬁned; however, the folding
of the remaining TM segments starting with TM10 remains controver-
sial. Three independent topology models predict that a signiﬁcant part
of the 5C region is exposed on the RBC surface [42–44], and two of
thesemodels suggest that a considerable part of the 6A region is also ex-
posed [43,44]. Recent determination of the structure of a band 3/AE1
membrane domain dimer at 7.5-Å resolution by electronmicroscopy re-
vealed a partial exposure of the 5ABC region, particularly the sequence
corresponding to the 5C region, and a somewhat ambiguous topology
of the 6A region [45,46]. Despite these structural insights, conclusive
biochemical validation of the accessibility of speciﬁc regions of band 3
in intact erythrocytes is lacking.
In this study, we developed two anti-band 3 antibodies in chicken
egg yolk using peptides patterned on the 5C and 6A regions of human
RBC band 3. Using these IgY antibodies, we provide conclusive evidence
that the two core regions of the band 3 invasion receptor, termed 5C and
6A are indeed exposed on the normal humanRBC surface. These anti-5C
and anti-6A antibodies inhibit RBC invasion by the 3D7 and 7G8 strains
of P. falciparum (SAID invasion phenotype) at a signiﬁcant rate when
added to the parasite culture medium. On the other hand, these anti-
bodies had little effect on blocking RBC invasion by the FCR3 and Dd2
strains (SAD invasion phenotype). We screened a yeast two-hybrid
P. falciparum cDNA library using the 5ABC fragment of human band 3
as bait, and identiﬁed parasite RhopH3 as an interaction partner. We
demonstrate the existence of a ternary complex between RhopH3,
MSP1 and band 3, and show that a putative extracellular domain of
RhopH3 inhibits parasite invasion in human RBCs. Taken together, our
results provide biochemical evidence that the 5C and 6A regions of
human band 3 forming the erythrocyte invasion receptor are exposed
on the host cell surface. These ﬁndings suggest that P. falciparumassembles a multi-protein complex containing RhopH3 and MSP1 on
RBC band 3 to facilitate entry via a SAID invasion pathway.
2. Materials and methods
2.1. Parasites
The 3D7A (MRA-151), 7G8 (MRA-152), FCR3 (MRA-158), and Dd2
(MRA-156) strains of P. falciparumwere obtained from the Malaria Re-
search and Reference Reagent Resource Center (Manassas, Virginia).
The 3D7 strain described here refers to the 3D7A strain (MRA-151). Par-
asites were maintained in culture as described [31]. Brieﬂy, parasites
were cultured in complete RPMI 1640 medium containing 0.5% w/v
Albumax II in a 5% CO2/1% O2/balance N2 gas mixture. The synchroniza-
tion of parasites at the ring stage using 5% sorbitol, and enrichment of
late-stage trophozoites using 63% (v/v) Percoll were carried out as
described [29].
2.2. Anti-band 3 IgY and anti-RhopH3 antibodies
Peptides ASTPGAAAQIQEVKE and FKPPKYHPDVPYVK derived from
the 5C and 6A regions of human erythrocyte band 3 (Fig. 1A) were
each conjugated to Keyhole Limpet Hemocyanin (KLH) by an N-
terminal cysteine coupling. Using these peptides, antibodies were pro-
duced in chickens by Sigma-Genosys. Following six injections given
every 14 days, eggs were collected and antibody titer was determined
by ELISA throughout the course of injections using blood serum. Total
IgY antibodies were puriﬁed from the egg yolk using the Eggcellent
Chicken IgY Puriﬁcation Kit (Pierce). Anti-5C and anti-6A IgY antibodies
were afﬁnity puriﬁed from corresponding total IgY using columns
prepared by conjugating the above antigen peptides to the CNBr-
activated resin (Pharmacia Biotech/GE Healthcare). The two mono-
speciﬁc IgY antibodies were stored in PBS at 4 °C. Eggs from two
preimmune chickenswere used to obtain total preimmune IgY antibod-
ies as above. Peptide RDSSSDRILLEESKTFT derived carboxyl region of
P. falciparum RhopH3was conjugated to KLH by an N-terminal cysteine
coupling. Antibodies against this peptide were raised in rabbit, and an-
tibody titer and puriﬁcation was performed as mentioned above. A
preimmune serum from rabbit was used as control.
2.3. Recombinant proteins, RBC ghosts, enzymatic treatment of RBCs, and
Western blotting
Total RNA was isolated from mixed stage culture of 8–10%
parasitemia. Infected RBCs were lysed with 0.15% saponin (1.5 vol) and
the parasite pellet was washed with PBS. Total RNA was isolated using a
TRIZOL reagent following the manufacturer's protocol (Invitrogen). The
C-terminal fragment of RhopH3 (1858–2691 base pairs) was ampliﬁed
from total RNA using the OneStep RT-PCR Kit (Qiagen) using the primers
5′-CGGGATCCTGTTTCTATCCAAAAGAATTTG-3′ and 5′-GCGTCGACCAAT
TCATTTTCAGAAGTAAAGGTTTTAG-3′. The ampliﬁed product was cloned
in pET32a expression vector (Novagen) to express fusionprotein contain-
ing thioredoxin (Trx) and hexa-histidine (His) tags at the N-terminus
and a His tag at the C-terminus. Expression of GST-5ABC using the
pGEX-2TK vector was described previously [29]. GST-6A was expressed
by cloning the 6A region (amino acids 807–826) of the human erythro-
cyte band 3 gene into the same pGEX-2TK vector as described [29]. Re-
combinant MBP-MSP119 and Trx-MSP119 were puriﬁed as described
previously [29]. The neuraminidase (Neu), chymotrypsin (C), and trypsin
(T) treatment of intact RBCs to remove/deplete sialic acid residues from
the RBC surface, and the preparation of human RBC ghosts were per-
formed as described [29]. Removal of sialic acid residues on the RBC
membrane was veriﬁed using a GlycoProﬁle III Fluorescent Glycoprotein
Detection Kit (Sigma), which is based on a modiﬁed Periodic Acid-Schiff
method. Brieﬂy, ghosts prepared from Neu-treated RBCs were subjected
to SDS-PAGE, and the gel containing separated RBC proteins was treated
Fig. 1.Generation of anti-band 3 IgY antibodies. (A) Alignment of the amino acid sequences of 5ABC,Δ5ABC, and 6A regions of human, chicken, andmouse RBC band 3. Chicken andmouse
sequences divergent from the human sequence are shown in red and underscored. Peptides patterned on the human 5C and 6A sequence to produce antibodies in chicken are underlined.
(B)Western blot showingmono-speciﬁc anti-5C (left panel) and anti-6A (right panel) IgY antibodies are reactive against the 5ABC and 6A domain of puriﬁedGST-fusion proteins, respec-
tively. Lanes 1 and 4, GST; lanes 2 and 5, GST-6A; and lanes 3 and 6, GST-5ABC. (C)Western blot showing anti-5C and anti-6A IgY antibodies reacting to full-length band 3 in human RBC
ghosts. A truncated band 3 band is also observed. Anti-band 3 mAb against the N-terminal cytoplasmic domain (B3/cd) and preimmune IgY were used as controls. Neu− (no Neu treat-
ment), ghosts from normal human RBCs. Neu+ (Neu treatment), ghosts from neuraminidase-treated intact human RBCs. (D) Staining of a polyacrylamide gel using Glyco-Pro (see Ma-
terials and methods) to verify the removal of sialic acid residues on the Neu-treated RBC membrane is shown. Neu− and Neu+ lanes are as above. Only in the Neu− lane, a single
ﬂuorescent band corresponding to dimeric GPA bearing most of sialic acids on the RBC surface is visible. This band is known to co-migrate with band 3, although not apparent in
Coomassie-stained gels [29]. Equal loading of ghost proteins was used in all immunoblotting experiments as observed by Coomassie staining (not shown).
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Carbohydrate-containing proteins were visualized as ﬂuorescent bands
directly on the gel using UV light.Western blottingwas carried out as de-
scribed [31]. The mAb (clone BIII-136, mouse ascite ﬂuid) against the N-
terminal cytoplasmic domain of human RBC band 3 (anti-B3/cd mAb)
was from Sigma. RBC binding experiments were performed as described
previously [16,47]. Brieﬂy, 100 pmol of soluble Trx-RhopH3-C protein
was incubatedwith 50 μl (packed cell volume) of normal and the enzyme
treated RBCs containing 1% fetal bovine serumat 37 °C for 2 hwith gentle
rocking, respectively. Themixturewas layered over dibutyl phthalate and
centrifuged, and the supernatant was discarded. Bound protein was elut-
ed with 15 μl of 1.5 M NaCl and analyzed byWestern blotting using anti-
His polyclonal antibody (GenScript). The Trx tag was used as a negative
control.2.4. Protein binding assays
For in vitro binding assays, different combinations of 50 pmol each of
Trx-RhopH3-C, Trx-MSP119, and GST-5ABC were added in a reaction
volume (200 μl) of binding buffer (50 mM Tris–HCl, pH 7.6, 1.0 mM
EDTA, 5.0 mM MgCl2, 0.1% NP40, 5.0 mM DTT, 1.0 mg/ml BSA and
150 mM NaCl) for 1.0 h at room temperature or overnight at 4 °C.
Bead-bound proteins were eluted and analyzed by Western blotting
using respective antibodies [29]. Parasite supernatant binding was per-
formed by adding 1 ml of culture supernatant to GST-5ABC protein
immobilized on glutathione beads. Following binding for 2 h at RT,beads were washed twice in RPMI, then eluted in SDS-sample buffer
and analyzed by immunoblotting against RhopH3. Empty vector
encoding GST was used as a negative control.
2.5. Immunoﬂuorescence microscopy
Thin smears of normal and Neu-treated RBCs were ﬁxed on glass
slides with cold methanol for 30 min, blocked with 1% BSA in PBS
(pH 7.4) for 30 min at RT, washed twice in PBS (5 min each), and incu-
bated with afﬁnity-puriﬁed anti-5C IgY or anti-6A IgY antibodies
(100 μg/ml in 1% BSA in PBS). Preimmune IgY (100 μg/ml), the anti-
B3/cd mAb, and the anti-GPA mAb reactive to extracellular residues of
human GPA (Sigma) were also used as control. Slides were washed
twice with PBS, incubated with appropriate secondary antibodies con-
jugated with Alexa 488 conjugate (green ﬂuorescence) or Alexa 594
(red ﬂuorescence) according to manufacturer's protocol (Invitrogen),
and visualized at 100×magniﬁcation. Negative control included incuba-
tion of slides with the Alexa 488-conjugated anti-chicken secondary
antibody alone.
2.6. Yeast two-hybrid library screen
The P. falciparum 3D7 cDNA library was constructed using a
HybriZap kit (Stratagene) from a pool of asynchronous parasite cul-
ture as described previously [29]. The bait construct pGBKT7-5ABC of
human band 3 was transformed into yeast Y187 (Clontech) lacking
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library screening was performed as described previously [30].
2.7. Quantitative ELISA
Quantiﬁcation of recombinant RhopH3-C to band 3 (5ABC) and
MSP119 was performed as described previously [30]. Brieﬂy, an ELISA
plate was coated with GST and GST-5ABC in carbonate buffer, pH 9.6,
at 4 °C overnight. After washing and blocking with PBS and PBST
(0.1% Tween 20) containing 5% milk, the Trx and Trx-RhopH3-C pro-
teins were added (0–5 μM). Upon incubation, bound protein was mea-
sured using anti-His polyclonal antibody (GenScript), anti-rabbit–HRP
conjugated antibody, and TMB substrate (Pierce). Similarly, Trx and
Trx-RhopH3-C were coated on the ELISA plate and MBP and MBP-
MSP119 were added to the wells in varying concentrations (0–6 μM).
Bound protein wasmeasured using an anti-MBP antibody (NE BioLabs).
Binding data were analyzed using SigmaPlot 11 (simple ligand binding
using the equation for one site saturation).
2.8. Detection of antibody binding to RBCs by ﬂow cytometry
Normal and Neu-treated intact human RBCs were washed with PBS
and resuspended in RPMI (50% hematocrit). A 100 μl sample of the RBC
suspension was incubated with anti-5C IgY (100 μg/ml), anti-6A IgY
(100 μg/ml), preimmune IgY (100 μg/ml), anti-B3/cd mAb, or anti-
GPA mAb for 30 min at 4 °C. After three washes with PBS, the RBCs
were resuspended in PBS containing FITC-conjugated anti-chicken or
anti-mouse secondary antibody for 45 min at 4 °C. Following three
washes with PBS, the cells were resuspended in 300 μl of PBS and
analyzed by recording 10,000 events using FACSCalibur (Becton
Dickenson) equipped with a 15 mW argon ion laser tuned at 488 nm.
Fluorescent cell analysis was performed on the population gated on
their forward scatter properties using the CellQuest (BD Bioscience)
and WinMDI 2.8 software (http://facs.scripps.edu/software.html). Sim-
ilarly, concentration-dependent binding of IgY antibodies to RBCs were
carried out as described above. Brieﬂy, normal and Neu-treated human
RBCs were each incubated with varying concentrations (0, 25, 50, 100,
250 μg/ml) of anti-5C IgY, anti-6A IgY, or preimmune IgY in PBS. Mean
ﬂuorescence intensity (mean ± s.e.) from triplicate assays was plotted
against the IgY concentration. Student 's t-test was used to compare
the mean. The dissociation constant (Kd) and maximum binding
(Bmax) for the IgY-RBC interaction was determined using the Ligand
Binding macro in SigmaPlot 8.0.
2.9. Estimation of parasitemia by ﬂow cytometry
P. falciparum-infected RBCs, either unsynchronized or synchronized
using sorbitol, were ﬁxed with freshly prepared 1% paraformaldehyde
in PBS for 1 h at RT. A 25 μl aliquot of the ﬁxed sample was incubated
with a 500 μl solution of cell-permeant nucleic acid dye, SYTO-13
(Invitrogen) in PBS for 15 min at RT. SYTO-13 was used at a single
ﬁnal concentration (50 or 100 nM) or a range of ﬁnal concentrations
(0–200 nM). To optimize assay conditions, SYTO-13 samples were ana-
lyzed by ﬂow cytometry as previously described [48]. The SYTO-13
green ﬂuorescence was detected using a 530 nm, 20 nm-bandwidth
band-pass ﬁlter. The ﬂow cytometry software package FCS Express
(DeNovo Software) was used for analysis and display of data. Five thou-
sand events were collected and a display of forward versus side scatter
was used to deﬁne a gate of RBCs. The percentage of cells with green
ﬂuorescence above backgroundwas analyzed froma density plot show-
ing side scatter on the x-axis and green ﬂuorescence intensity on the y-
axis (Fig. 4C) or a one-parameter histogram representing green ﬂuores-
cence intensity on a logarithmic scale (Fig. 5). Uninfected RBCs were
used as control. Assay conditions optimized for estimating parasitemia
were reproducible using FACSCalibur as described above (data not
shown). The accuracy of estimating parasitemia by our ﬂow cytometrymethod was compared with the conventional visual counting method
using Giemsa-stained thin smears under a microscope. The two
methods gave comparable parasitemia (data not shown).
2.10. RBC invasion inhibition assay
P. falciparum fraction enriched with late-stage trophozoites (N90%
enrichment using 63% Percoll) from a sorbitol-synchronized culture
was returned to culture by incubating the parasites with fresh normal
or Neu-treated human RBCs in a 96-well microplate (ﬁnal, 2% hemato-
crit, 1.5–3.5% parasitemia). An aliquot of anti-5C and/or anti-6A IgY
antibodies (as inhibitor) passed through a 0.2 μm ﬁlter was added to
the culture medium. For concentration-dependent inhibition assays,
ﬁnal IgY concentrations used for each preimmune IgY (control), anti-
5C IgY, and anti-6A IgY antibodies were 25, 50, 100, and 200 μg/ml.
Samples containing a 1:1 mixture of two IgY antibodies were prepared
by adding each IgY at 25, 50, 100, and 200 μg/ml ﬁnal concentrations.
A control sample having no IgY antibodies was included. For the
invasion phenotype-speciﬁc inhibition study, anti-5C IgY, anti-6A
IgY, or preimmune IgYwas used at the 100 μg/ml ﬁnal concentration.
The assay was allowed to continue for 20–22 h under standard
P. falciparum culture conditions and stopped by treating the samples
with freshly made 1% paraformaldehyde as mentioned above. Upon
collecting 10,000 events using FACSCalibur, parasitemia for each sample
was determined based on the newly formed ring-stage parasites at the
50 nM concentration of SYTO-13. For the invasion phenotype-speciﬁc
inhibition study using recombinant proteins, 8 μM GST-5ABC or GST
(control) was added as the inhibitor. A similar protocol was used for
measuring the invasion inhibitory effect of Trx-RhopH3-C. The invasion
assay was carried out as described above. At the end of the assay, thin
smearsmade fromeach samplewere stainedwith Giemsa and analyzed
visually under a microscope at 100× magniﬁcation. Approximately
1500 cells were counted for each sample and parasitemia estimated
based on the number of newly formed ring-stage parasites. All assays
were carried out in triplicates and data plotted as percent invasion inhi-
bition (mean ± s.e.). Student's t-test was used to compare the mean.
3. Results
3.1. Generation and speciﬁcity of chicken IgY antibodies reacting to human
RBC band 3
We generated antibodies against the 5C and 6A regions of human
RBC band 3 (Fig. 1). These two regions are thought to shape the core
of the band 3 invasion receptor based on our earlier studies [29–31],
and have been predicted to adopt extracellular orientation in some to-
pology models [42–44]. Because human and mouse band 3 polypep-
tides share very high sequence identity in these regions (Fig. 1A), we
had little success in inducing an immune response against human 5C
or 6A sequences in mice. However, we succeeded in producing anti-5C
and anti-6A antibodies in chicken egg yolk using short peptides derived
from human 5C and 6A as immunogens. Antibody titers were relatively
low for both 5C and 6A based on ELISA even after several injections
(data not shown), presumably due to high sequence homology in
these regions of band 3 between human and chicken.
Afﬁnity-puriﬁed anti-5C and anti-6A IgY antibodies reacted speciﬁ-
cally to recombinant proteins GST-5ABC and GST-6A, respectively, by
Western blot (Fig. 1B). Further, anti-6A speciﬁcally recognized band 3
in RBC ghosts prepared from normal human RBCs (Fig. 1C). However,
anti-5C IgY failed to react to band 3 in the normal RBC ghost sample in
Western blot (Fig. 1C). Interestingly, when the RBC ghost sample was
prepared from human RBCs pretreated with neuraminidase (Neu) to
remove sialic acid residues from the cell surface (Fig. 1D), the anti-5C
IgY reactivity to band 3 was restored under the same conditions
(Fig. 1C). Although the precise reason of this differential reactivity re-
sponse is not yet known, onemay speculate that the sialic acid residues
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anti-5C IgY to its 5C epitope on band 3 under these Western blotting
conditions. Sialic acid residues had no appreciable effect on the reactiv-
ity of anti-6A IgY antibodies to band 3 in Western blot (Fig. 1C). As a
positive control, a monoclonal antibody (mAb) against the N-terminal
cytoplasmic domain of human band 3 (Sigma) was used to detect
band 3 in normal andNeu-treated RBC ghosts. Puriﬁed preimmune con-
trol IgY showed no reactivity to either the recombinant proteins (not
shown) or the human RBC ghost proteins (Fig. 1C). These results indi-
cate the generation of two afﬁnity-puriﬁed mono-speciﬁc antibodies,
anti-5C and anti-6A IgY, reactive against human RBC band 3.
3.2. Interaction of anti-band 3 IgY antibodies with RBCs
Since anti-5C and anti-6A IgY antibodies showed characteristic band
3 recognition patterns on RBC ghosts in Western blot (Fig. 1C), we in-
vestigated their band 3-binding properties on intact RBCs. In the ﬁrst
method, we examined the binding of anti-5C IgY and anti-6A IgY to
methanol-ﬁxed human RBCs by immunoﬂuorescence microscopy. Nor-
mal RBCs (Fig. 2A) as well as sialic acid-depleted RBCs prepared by
treating the intact cells with Neu prior to ﬁxing (Fig. 2B) were used. In-
direct immunoﬂuorescence assay (IFA) showed that both anti-5C and
anti-6A antibodies speciﬁcally bound to normal and Neu-treated RBCs.
The control preimmune IgY as well as the anti-chicken secondary anti-
body alone did not show any interaction with ﬁxed RBCs. As a positive
control, the anti-band 3 mAb bound to both normal and Neu-treated
RBCs as methanol ﬁxation permeabilized the membrane enabling anti-
bodies to react to proteins in the intracellular compartments (Fig. 2A, B).
As expected, the monoclonal anti-GPA antibody/clone E4 (Sigma)
raised against extracellular residues of human GPA, which are sensitive
to sialic acid residues, interacted with normal RBCs bearing sialic acidFig. 2. Reactivity of antibodies to ﬁxed RBCs by indirect immunoﬂuorescence assay. (A) Normal
GPAmAb against extracellular residues, anti-band 3mAb against the cytoplasmic domain (anti
shown (100×magniﬁcation). Secondary antibodies were conjugated to either Alexa 488 or Ale
lower panel. (B) This panel shows reactivity to antibodies, as in panel A, in the neuraminidaseresidues, but not with Neu-treated RBCs where sialic acid residues on
the RBC surface have been depleted (Fig. 1D).
In the second method, we examined the binding of anti-5C IgY and
anti-6A IgY to RBCs in suspension. Normal and Neu-treated intact
human RBCs were reacted with the anti-5C and anti-6A antibodies
(100 μg/ml) and analyzed by ﬂow cytometry. As compared to the
preimmune IgY control, histograms showed that each anti-5C IgY and
anti-6A IgY bound to both normal and Neu-treated RBCs (Fig. 3). The
anti-5C IgY showed a stronger interaction with the sialic acid-depleted
RBCs than normal RBCs in suspension as indicated by higher ﬂuores-
cence intensity. This observation is consistent with the earlier Western
blot result (Fig. 1C) where the reactivity of anti-5C IgY to band 3 in
the RBC ghosts was apparent only in the Neu-treated RBCs. The anti-
band 3 mAb reactive to the N-terminal cytoplasmic domain of band 3
did not bind to either normal or Neu-treated RBCs indicating that the
cells were fully intact (Fig. 3). The anti-GPAmAb reactive to surface res-
idues of human GPA bound to normal RBCs but not with Neu-treated
RBCs consistent with the IFA results (Fig. 3). These results demonstrate
that the anti-5C and anti-6A IgY antibodies react to the extracellular
epitopes of band 3 on the surface of normal andNeu-treated intact RBCs.
3.3. Concentration-dependent binding of anti-band 3 IgY antibodies to RBCs
To quantitatively characterize the interaction of IgY antibodies with
intact RBCs, we carried out a concentration-dependent binding of the
antibodies using the above ﬂow cytometry method. The data presented
as mean ﬂuorescence intensity versus IgY concentration showed that
the binding of anti-5C and anti-6A IgY to intact human RBCs is indeed
concentration dependent in both normal and Neu-treated cells
(Fig. 4A, B). The non-speciﬁc binding of preimmune IgY to RBCs was
negligible. In normal RBCs, the maximum binding (Bmax) for anti-5Chuman RBCs reacting to anti-chicken secondary antibody (conjugated to Alexa 488), anti-
-band 3/cd), preimmune IgY, mono-speciﬁc anti-5C IgY, andmono-speciﬁc anti-6A IgY are
xa 594 to produce green or red ﬂuorescence, respectively. Phase contrast is shown in the
-treated (Neu) RBCs.
Fig. 3.Binding of antibodies to intact RBCs by ﬂowcytometry. Binding data obtained byﬂowcytometrywere analyzed using histograms (x-axis, ﬂuorescence intensity in logarithmic scale;
y-axis, number of events) and then plotted on an identical x-axis (100–104 scale) for a visual comparison of ﬂuorescence intensity. In both normal and Neu-treated RBC samples, binding
measurementswere performedwith the following antibodies: anti-chicken secondary antibodies as controls, anti-band 3mAb against the cytoplasmic domain (anti-band 3/cd), anti-GPA
mAb against extracellular regions, andpreimmune IgY. Fluorescence intensity for the binding ofmono-speciﬁc anti-5C and anti-6A IgY antibodies (100 μg/ml) to RBCswas comparedwith
the preimmune IgY (100 μg/ml) control.
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Fig. 4. Binding of anti-band 3 IgY antibodies to human RBCs, and detection of parasitemia. (A) The concentration-dependent binding of anti-5C and anti-6A IgY antibodies (0, 25, 50, 100,
250 μg/ml) to human RBCs is shown.Mean ﬂuorescence intensity (y-axis) was obtained from triplicatemeasurements using ﬂow cytometry. The binding of preimmune IgY at all concen-
trationswas insigniﬁcant. (B) Identical assay to (A) butwith neuraminidase-treated RBCs. (C) Density plot analysis of parasitemia estimation by ﬂow cytometry using SYTO-13. Culture of
P. falciparum (3D7 strain) at amixed stagewas split into two samples. One samplewas synchronizedwith sorbitol,while the otherwas kept as themixed stage.When synchronized culture
reached the trophozoite stage, both culture samples were ﬁxed with 1% paraformaldehyde in PBS. An aliquot (25 μl) of the ﬁxed sample was added to a 500 μl solution of SYTO-13 in PBS
(ﬁnal concentration 100 nM) and subjected to ﬂow cytometry as described in Materials and methods. The density plot for each sample is shown with side scatter on the x-axis and FL2
(SYTO-13) on the y-axis, respectively, in logarithmic scale. While the mixed-stage sample (Infected/Unsync) contained young ring-stage parasites (R) as well as mature trophozoites (T),
synchronized culture sample (Infected/Sync) showed predominantly trophozoites. Uninfected RBCs were used as control.
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(Table 1). The dissociation constant (Kd), however, remained relatively
unchanged in both RBC samples. In contrast, Neu treatment did not
have any signiﬁcant effect on the binding of anti-6A IgY to or dissocia-
tion of the IgY from intact RBCs (Fig. 4B). Together, data fromWestern
blotting, immunoﬂuorescence microscopy, and ﬂow cytometry provide
compelling evidence that the 5C and 6A regions of band 3 are exposed
on the surface of normal human RBCs. Removing sialic acid residues
from the cell surface by the Neu treatment of intact RBCs enhances the
recognition of the band 3 epitopes, particularly by the anti-5C IgY. Inter-
estingly in our previous study [29], the rate of binding of P. falciparum
MSP119 and MSP142 to native band 3 on the RBC surface increased
when sialic acid residues were removed from the RBC surface by Neu
treatment.Table 1
Equilibrium binding constants.
Antibodies Bmax
(mean ﬂuorescence intensity)
Kd (μg/ml)
Normal RBCs Neu-treated RBCs Normal RBCs Neu-treated RBCs
Anti-5C IgY 8.2 ± 0.7 25.8 ± 2.7 25.7 ± 7.9 36.6 ± 12.5
Anti-6A IgY 19.6 ± 1.7 20.7 ± 1.4 32.7 ± 9.6 43.7 ± 8.93.4. Flow cytometry analysis of parasitemia using SYTO-13
To analyze a large number of samples generated from the RBC rein-
vasion assay by a reliable and convenient method, we developed a new
ﬂow cytometry method as described in the Materials and methods sec-
tion. This method uses cell-permeant nucleic acid dye SYTO-13
(Invitrogen) to accurately estimate parasitemia in the assay samples
(Fig. 5). Because it is not necessary to permeabilize the cells for SYTO-
13 to function properly, parasites and RBCs in the sample remain
much more stable especially from cell lysis for a prolonged time (over
3 days). SYTO-13 is a green ﬂuorescent dye having absorption and
emission at 488 nm and 509 nm, respectively, which is suitable for a
large selection of commonly used instruments. In contrast, the vital
dye Hoechst [49] often used to stain stage-speciﬁc malaria parasites
requires a ﬂow cytometer equipped with a UV laser. SYTO-13 has high
molar absorption (N50,000 cm−1 M−1) giving low intrinsic ﬂuores-
cence associated with the background. These salient features of SYTO-
13 allowed analysis to readily distinguish different populations of
stage-speciﬁc parasites from uninfected RBCs in the P. falciparum cul-
ture using aﬂow cytometer (Fig. 4C). Other nucleic acid dyes such asAc-
ridine Orange, Thiazole Orange, YOYO-1, YO-PRO-1, and DRAQ5 did not
give satisfactory results in our hands. We found that 50 nM SYTO-13
gave an excellent distinction of cell populations between uninfected
RBCs and infected RBCs at the ring, trophozoite, and schizont stages,
with relatively low background ﬂuorescence (Fig. 4C). The parasitemia
Fig. 5. Histogram analysis of parasitemia by ﬂow cytometry using SYTO-13. A mixed-stage P. falciparum culture was ﬁxed as above and added to SYTO-13 solution to give a ﬁnal concen-
tration of SYTO-13 at 0, 12.5, 25, 50, 100, 150, and 200 nM in saline. Uninfected RBC samples were used as control. Flow cytometry data for infected and uninfected RBC samples were
plotted as a histogram showing FL2 (SYTO-13) on the x-axis in logarithmic scale (100–104) and number of events on the y-axis. At 50 nM SYTO-13, uninfected RBCs (black arrowhead),
ring-stage parasites (blue arrow), trophozoites (red arrow), and early schizonts (black arrow) had a clear baseline separation in the histogram. At 100 nM SYTO-13, there was a similar
distinction of the cell populations but the background ﬂuorescence was higher.
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method using Giemsa-stained thin smears by microscopy (data not
shown).
3.5. Blocking P. falciparum invasion in human RBCs using anti-band 3 IgY
Since the binding of anti-5C and anti-6A IgY antibodies to the RBC
surface was concentration-dependent, we investigated whether these
antibodies would block the reinvasion of RBCs by P. falciparum when
added to the culture medium. The invasion blocking assay was carried
out in the P. falciparum (3D7 strain) culture as described [29] using
mono-speciﬁc anti-5C IgY and anti-6A IgY, either independently or to-
gether. The range of IgY concentrations used was similar to the above
RBC binding assay. Assaymixtures were analyzed by the above ﬂow cy-
tometry method to quantify newly formed ring-stage parasites and cal-
culate percent parasitemia for each sample (Table 2). To visualize the
invasion blocking effect of IgY antibodies, results are presented as the
percent inhibition of invasion at a given IgY concentration, by taking
the preimmune IgY sample at the equivalent concentration as 0% inhibi-
tion (or 100% invasion). In both normal and sialic acid-depleted RBC
samples, anti-5C IgYwas superior in blocking RBC invasion as compared
to anti-6A IgY (Fig. 6A, B). Consistent with its RBC binding property, the
rate of invasion inhibition for anti-5C IgY was signiﬁcantly higher
(about 2–3 fold) in the sialic acid-depleted RBCs throughout the IgY
concentrations. At 200 μg/ml IgY concentration, the anti-5C IgY blocked
RBC invasion by 58% as compared to the preimmune IgY, which had no
detectable effect on invasion at all concentrations. Although the Bmax for
anti-5C IgY binding to normal RBCs was about two-fold less than for
anti-6A IgY (Table 1), the rate of RBC invasion inhibition for anti-5C
IgY was about two-fold higher than for anti-6A IgY (Fig. 6A). No accu-
mulation of trophozoites and schizonts was observed during the course
of the assay, indicating that the addition of antibodies to the culture
medium at the trophozoite stage did not affect intracellular maturation
and release of the parasites.
When both anti-5C and anti-6A antibodieswere added to the culture
medium as a 1:1 mixture, an additive effect was observed (Fig. 6,
Table 2). It was also evident that this additive effect was not simply
due to the doubling of the total IgY concentration. For example, in nor-
mal RBC samples, 100 μg/ml anti-5C IgY produced 18% invasion inhibi-
tion, while a mixture of 50 μg/ml anti-5C IgY and 50 μg/ml anti-6A IgY
gave 29% inhibition. Similarly, doubling the anti-5C IgY concentration
from 25 to 50 μg/ml increased the inhibition rate from 12% to 29% inhi-
bition in Neu-treated RBC samples, but adding 25 μg/ml of each IgY as a
mixture resulted in only 20% invasion inhibition. These results suggest
that each anti-5C and anti-6A IgY plays an important role in blocking
RBC invasion by P. falciparum. The rate at which each anti-5C IgY and
anti-6A IgY binds to RBCs (Fig. 4A, B) and blocks RBC invasion (Fig. 6A,
B) over a similar range of IgY concentrations appear to have a close
resemblance. Both the binding of and invasion inhibition by each IgY
increased at a rapid rate until about 50 μg/ml concentration. However,Table 2
IgY concentration-dependent inhibition of RBC invasion by the P. falciparum 3D7 strain.
RBCs IgY % Parasitemia (mean ± s.e)
IgY concentration (μg/ml)
0 25
Normal Pre-immune 3.19 ± 0.03 2.99 ±
Anti-5C – 2.31 ±
Anti-6A – 2.61 ±
Both – 1.37 ±
Neu- treated Pre-immune 1.39 ± 0.01 1.35 ±
Anti-5C – 0.97 ±
Anti-6A – 1.11 ±
Both – 0.44 ±the binding and the inhibition slowed down signiﬁcantly starting at
about 100 μg/ml of IgY and reached near maximum at 200–250 μg/ml.
These similar rate proﬁles suggest that the invasion blocking effect of
the anti-band 3 IgY antibodies correlates with the binding of these anti-
bodies to their respective epitopes, the 5C and 6A regions of band 3 on
the human RBC surface.
3.6. Invasion phenotype-speciﬁc inhibition of RBC invasion
In our previous studies, we showed that 5C and 6A regions of RBC
band 3 function as an invasion receptor interacting with P. falciparum
merozoite surface proteins, MSP142/MSP119 andMSP9 by a SAIDmech-
anism [29,30]. In this study, our data show that both anti-5C and anti-6A
antibodies blocked RBC invasion by the P. falciparum 3D7 strain, which
favors the SAID invasion pathway (Fig. 6). Hence, we asked whether
the invasion-blocking function of anti-5C and anti-6A antibodies is lim-
ited to a speciﬁc invasion phenotype of P. falciparum. To investigate this
possibility, we carried out the RBC invasion assays using 3D7 and 7G8
strains representing the SAID invasion phenotype, and FCR3 and Dd2
strains representing the SAD invasion phenotype. The concentration of
IgY antibodies added as inhibitors in the assay was 100 μg/ml. Normal
and sialic acid-depleted (Neu-treated) RBCs were used. Newly formed
ring-stage parasites were quantiﬁed and parasitemia determined for
each assay sample (Table 3) using the ﬂow cytometry method. When
the data are presented as percent inhibition of RBC invasion by taking
the preimmune IgY control as 0% inhibition, it was evident that anti-
5C IgY blocked RBC invasion by the SAID invasion phenotype of
P. falciparum in both normal and sialic acid-depleted RBC samples
(Table 3) (Fig. 7). However, the effect of anti-5C IgY on the SAD invasion
phenotype was marginal in both RBC types. In comparison, the anti-6A
IgY antibodies showed a relatively weak, yet nevertheless, signiﬁcant
inhibitory effect onRBC invasion by the SAID invasion phenotype partic-
ularly in Neu-treated samples (Table 3). In normal RBC samples, anti-6A
IgY alone had little effect on blocking RBC invasion by either invasion
phenotype (Table 3). These results, obtained at 100 μg/ml IgY concen-
tration, are consistent with experiments over a range of IgY concentra-
tions using only the 3D7 strain (Fig. 6).
Since the anti-5C IgY antibody showed a signiﬁcant inhibitory effect
on the invasion of RBCs by the SAID invasion phenotype, we asked
whether the human RBC band 3 peptide, 5ABC, would have a similar in-
vasion blocking effect and invasion phenotype speciﬁcity. The invasion
blocking mechanism for the 5ABC peptide is thought to be distinct
from anti-5C IgY. The 5ABC peptide mimicking the band 3 receptor is
expected to interact directly with the parasite ligand(s) in competition
with band 3, whereas anti-5C IgY would bind to band 3 epitopes and
block the band 3 invasion receptor function. However, we anticipated
a similar result because in principle both types of inhibition approaches
would disrupt interaction between the host receptor band 3 and the
parasite ligand(s) during RBC invasion. Considering the mechanism of
invasion inhibition by the 5ABC peptide, it was not necessary to use50 100 200
0.14 3.01 ± 0.11 3.00 ± 0.02 2.98 ± 0.11
0.04 1.97 ± 0.02 1.89 ± 0.03 1.78 ± 0.02
0.03 2.21 ± 0.04 2.16 ± 0.13 2.11 ± 0.01
0.04 1.16 ± 0.01 1.00 ± 0.12 1.04 ± 0.02
0.07 1.29 ± 0.06 1.30 ± 0.03 1.41 ± 0.01
0.11 0.67 ± 0.03 0.58 ± 0.01 0.53 ± 0.01
0.01 0.98 ± 0.01 0.87 ± 0.02 0.81 ± 0.07
0.03 0.21 ± 0.01 0.16 ± 0.05 0.17 ± 0.02
Fig. 6. Antibody and peptide-dependent inhibition of Plasmodium falciparum invasion in RBCs. (A) RBC invasion assay was carried out using freshly added normal or (B) Neu-treated
human RBCs in trophozoite-enriched P. falciparum (3D7 strain) samples having different concentrations of anti-band 3 IgY antibodies (see Materials and methods). Each anti-5C and
anti-6A IgY was used at 0, 25, 50, 100, and 200 μg/ml concentrations either as a single inhibitor or as a mixture of the two. Newly formed ring-stage parasites were counted by the
ﬂow cytometry method using SYTO-13, and mean parasitemia (new infection) was determined from triplicate assay samples. The data are presented as percent invasion inhibition
(mean± s.e.) based on the preimmune IgY control sample taken as 0% inhibition (or 100% invasion). (C) Invasion inhibition assays were carried out for both SAID and SAD invasion phe-
notypes of P. falciparum. The assayswere performed in triplicate using 8.0 μMof soluble recombinant proteins, GST-5ABC andGST (control). Student's t-testwas used to compare themean.
The data presented as percent invasion inhibition is based on the GST control sample taken as 0% inhibition. (D) Illustration of the proposed model of the band 3–parasite interactions
occurring at both 5C and 6A regions. Invasion is reduced when these interactions are inhibited through the use of recombinant peptides or antibodies against these regions.
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using only normal RBCs in P. falciparum cultures containing 3D7, 7G8,
FCR3, and Dd2 strains. Soluble GST-5ABC was used as the inhibitor
and GST as control each at 8 μM concentration. The results are plotted
as percent inhibition of RBC invasion taking the GST control as 0%. Inva-
sion inhibition by the 5ABC peptide was strikingly signiﬁcant in the
SAID invasion phenotype of P. falciparum (48–65% inhibition), while it
was marginal in the SAD invasion phenotype (b10% inhibition)Table 3
Inhibition of RBC invasion using 3D7, 7G8, FCR3, and Dd2 strains of P. falciparum.
Strains RBCs % Parasitemia (mean ± s.e.)a
Anti-6A
IgY inhibitors
Pre-immune Anti-5C
3D7 Normal 3.63 ± 0.03 1.73 ± 0.07 2.63 ± 0.03
Neu-treated 0.97 ± 0.18 0.57 ± 0.01 0.86 ± 0.05
7G8 Normal 2.69 ± 0.07 1.56 ± 0.03 2.18 ± 0.04
Neu-treated 1.02 ± 0.06 0.39 ± 0.01 0.75 ± 0.02
FCR3 Normal 3.11 ± 0.01 4.04 ± 0.24 2.96 ± 0.02
Neu-treated 0.22 ± 0.05 0.12 ± 0.07 0.17 ± 0.03
Dd2 Normal 3.77 ± 0.13 2.71 ± 0.04 3.11 ± 0.22
Neu-treated 0.17 ± 0.15 0.09 ± 0.01 0.11 ± 0.01
a (Number of ring-infected RBCs after invasion / Total RBCs) × 100.(Fig. 6C). No accumulation of trophozoites and schizonts was observed
in any samples during the course of the assay (data not shown) indicat-
ing that recombinant proteins, GST-5ABC and GST did not affect intra-
cellular maturation and release of the parasites. Together, these results
indicate that 5C and 6A regions of human band 3 are exposed on the
RBC surface and serve as a host invasion receptor predominantly in
the SAID invasion pathway. It appears that the 5C region in particular
is an exceptionally important part of the band 3 invasion receptor
(Fig. 6D).
3.7. Interaction of P. falciparum RhopH3 with human RBC band 3
Identiﬁcation of the 5ABC region of host RBC band 3 as an invasion
receptor raised the possibility that the parasite might utilize multiple
ligands to interact with this region, either directly or indirectly to facil-
itate pathogen entry into host cells. To test this possibility, we per-
formed a yeast two-hybrid screen of a P. falciparum cDNA library
(3D7, a SAID strain) using the 5ABC peptide (amino acids 720–761) of
human RBC band 3 as bait [30]. Sequencing of at least three clones
revealed the C-terminal region of RhopH3 protein (amino acids
431–876) as the binding segment (Fig. 8A). RhopH3 is a component of
the highmolecularweight complex (HMW)of rhoptry proteins [50]. Al-
though the precise membrane topology of RhopH3 is not yet known,
Fig. 7. Invasion phenotype-speciﬁc inhibition of P. falciparum invasion into RBCs. (A–D) Using 100 μg/ml of anti-5C, anti-6A, and preimmune IgY as inhibitors, invasion inhibition assays
were carried out for both SAID and SAD invasion phenotypes of P. falciparum. The assays were performed in triplicate using normal and Neu-treated RBCs. Flow cytometry using SYTO-13
allowed rapid analysis ofmultiple assay samples as described before. Results are presented as percent invasion inhibition (mean± s.e.) where the preimmune IgY samplewas taken as 0%
inhibition. Student's t-test was used to compare the mean.
Fig. 8. Identiﬁcation of band 3–RhopH3 interaction by the yeast two-hybrid screen. (A) Diagram of full-length RhopH3 protein with its predicted transmembrane domains colored in red
[47], the antibody epitope used in this study is shown in green, and the region identiﬁed as binding to the 5ABC domain of band 3 in a Y2H screen is colored in yellowmarkedwith arrows.
Recombinant RhopH3was expressed by excluding the predicted transmembrane domains for optimumprotein stability. This construct contains an N-terminal thioredoxin (Trx) tag, and
both an N-terminal and C-terminal 6-His tag, and itwas termed Trx-RhopH3-C. (B) Puriﬁed recombinant proteins include Trx-RhopH3-C, its band 3-binding site (GST-5ABC), Trx-MSP119,
and respective fusion tags (MBP, Trx, and GST). Gel was stained with Coomassie blue. (C) Polyclonal antibody was raised against the RhopH3 peptide (amino acids 876–892), and char-
acterized by ELISA and Western blotting. This antibody was used to conﬁrm the identify recombinant Trx-RhopH3-C byWestern blotting.
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domains embedded within the primary structure of RhopH3 [47].
The ConPred II [51] program predicted a transmembrane region
(amino acids 593–613) within the yeast two-hybrid clone of
RhopH3 (Fig. 8A). Thus, we excluded the predicted transmembrane
domain(s) to express a shorter segment of RhopH3 (amino acids
620–897), termed RhopH3-C, in order to validate its biochemical interac-
tion with the 5ABC peptide of RBC band 3 (Fig. 8A). The RhopH3-C
segment was expressed as a fusion protein containing Trx and His tags
with an apparent mass of 52 kDa (Trx-RhopH3-C) (Fig. 8B). In addition,
we developed an afﬁnity-puriﬁed polyclonal anti-peptide (amino acids
876–892; Fig. 8A) antibody against RhopH3 to conﬁrm the identity and
intactness of recombinant RhopH3-C protein (Fig. 8C). The 5ABC peptide
of band 3 was expressed as a GST fusion protein of 32 kDa (Fig. 1B).
Solution binding assays conﬁrmed speciﬁc biochemical interaction
between Trx-RhopH3-C and 5ABC peptide immobilized to glutathi-
one beads (Fig. 9A). The afﬁnity of Trx-RhopH3-C interaction with
5ABC, as measured by a quantitative ELISA, yielded a Kd value of
183 nM ± 0.111 (Fig. 9B). A truncated version of the 5ABC peptide
(Δ5ABC), lacking the last 19 amino acids, partially lost Trx-RhopH3-C
binding activity (Fig. 9A). Together, these results indicate that the C-
terminal segment of RhopH3 directly interacts with the 5ABC region
of human RBC band 3.Fig. 9. Biochemical interactions between RhopH3, Band 3, and MSP1. (A) The 5ABC region of
RhopH3-Cwas added to themixture and allowed to bind. Afterwashing, bound proteinwas elu
(B) Concentration-dependent binding of soluble Trx-RhopH3-C (0–5 μM) to GST-5ABC (0.1 μM)
was estimated from duplicate measurements. The ligand binding curves are shown in the rang
MBP fusion protein was immobilized to amylose beads. Trx-RhopH3-C was added to the mixtu
detect the RhopH3-C fusion protein. (D) Concentration-dependent binding of soluble MBP-MSP
curves are shown in the range of 0–6 μM. Trx-RhopH3 binding to MBP and Trx binding to MBP
5ABC protein, and binding was detected by immunoblotting using anti-RhopH3 serum. All pu
times.3.8. Biochemical interactions between RhopH3, MSP1, and band 3
A global interaction network analysis of P. falciparum predicted a
major role of MSP1 by virtue of its interactions with more than 80
proteins in the malaria genome [32]. Consistent with the interaction
network, the C-terminal 19 kDa segment of MSP1 (MSP119) interacted
with the C terminal segment (amino acids 734–865) of RhopH3 [32,
47]. To assess the inter-dependence of biochemical interactions be-
tween RhopH3, MSP1, and band 3, we expressed MSP119 (amino acids
1665–1760) as a fusion with maltose binding protein (MBP) (Fig. 8B).
Amylose beads with immobilized MBP-MSP119 speciﬁcally bound solu-
ble Trx-RhopH3-C indicating a direct biochemical interaction (Fig. 9C).
The afﬁnity of Trx-RhopH3-C interaction with MBP-MSP119, as mea-
sured by an ELISA, yielded a Kd value of 390 nM ± 0.032 (Fig. 9D).
Since RhopH3 interacts directly with both MSP1 and 5ABC and
MSP119 is known to bind to 5ABC, we developed a competitive binding
assay to evaluate the inter-dependence of RhopH3 andMSP119 interac-
tions with 5ABC. For this assay, MSP119 was expressed as a Trx fusion
protein (Fig. 8B), and ternary interactions between MSP19, RhopH3,
and 5ABC were examined (Fig. 10A). Glutathione beads saturated
with GST-5ABC were incubated with an equimolar concentration of
Trx-RhopH3-C to allow saturation binding (Fig. 10B). Trx-MSP119 was
then added at increasing molar ratios (1, 2.5, 5, and 10) to compete offband 3 was expressed as a GST fusion protein, which was then bound to GSH resin. Trx-
ted and analyzed by immunoblotting against theHis tag to detect RhopH3-C fusion protein.
immobilized to an ELISA plate. The values aremeans± S.D., and the dissociation constant
e of 0–5 μM. Trx binding to GST-5ABC and GST was insigniﬁcant. (C) MSP119 expressed as
re, allowed to bind, washed, and eluted. Immunoblotting against the His tag was used to
119 (0–6 μM) to Trx-RhopH3-C (0.1 μM) immobilized to an ELISA plate. The ligand binding
were insigniﬁcant. (E) Parasite culture supernatant was incubated with immobilized GST-
ll-down binding assays were performed at least two times and some were repeated 4–5
Fig. 10. Competitive displacement of interactions between RhopH3, band 3, and MSP1
binding domains. (A) 5ABC peptide of band 3 was expressed as GST fusion protein
bound to GSH resin beads. Beads were allowed to interact with Trx-RhopH3-C, followed
by the addition Trx-MSP119 at varying concentrations. (B) Bound proteins were eluted
and analyzed by immunoblotting against the His tag to detect Trx-RhopH3-C and Trx-
MSP119 fusion proteins. Trx-RhopH3-C was added to saturate the binding sites of GST-
5ABC on beads. Increasing amounts of Trx-MSP119 were added to determine the displace-
ment of RhopH3-C interaction with the GST-5ABC peptide immobilized onto beads.
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gressively displaced RhopH3 from 5ABC at increasing molar concentra-
tions (Fig. 10B). At 10 M excess of MSP119, the MSP119 and RhopH3-C
formed a ternary complexwith 5ABC suggesting a concentration depen-
dent occupancy of the binding sites under these conditions. Additional-
ly, a parasite supernatant binding assay was performed to test for
endogenous RhopH3 binding to 5ABC. Parasite supernatant demon-
strated a very low abundance of endogenous RhopH3, detectable only
by immunoblotting; however, this endogenous protein speciﬁcally
bound 5ABC protein immobilized on GST beads (Fig. 9E). Thus, in addi-
tion to recombinant RhopH3-C, native RhopH3 demonstrates a speciﬁc
interaction with 5ABC.
3.9. RhopH3 inhibits P. falciparum invasion in human RBCs
Trx-RhopH3-C binds speciﬁcally to human RBCs in a solution
binding assay (Fig. 11A). Since Trx-RhopH3-C binds to the 5ABC region
of band 3 (Fig. 9A), its interaction with intact RBCs was unaffected upon
treatment of RBCs with either neuraminidase (Neu) or trypsin
(T) (Fig. 11A). In fact, binding of Trx-RhopH3-C to RBCs was slightly in-
creased upon trypsin treatment of RBCs, presumably due to the removal
of glycophorin A from the glycophorin A–band 3 complex (Fig. 11A).
The chymotrypsin treatment of RBCs is known to cleave RBC band 3
into two lowerMWbands thatwould retain the5ABCpeptide sequence
(Fig. 11B, C). Indeed, chymotrypsin treatment (C) of RBCs did not affect
the Trx-RhopH3-C interaction under the same assay conditions
(Fig. 11A). Moreover, Trx-RhopH3-C binding to RBCs that were sequen-
tially treated with trypsin, chymotrypsin, and neuraminidase (TT) es-
sentially remained unchanged (Fig. 11A). These results suggest that
RhopH3 binds to RBCs in a sialic acid-independent manner. We thentested the inhibitory activity of Trx-RhopH3-C on P. falciparum (3D7) in-
vasion in human RBCs. Because of the technical limitations of limited
solubility and stability, the Trx-RhopH3-C fusion protein was used
only at two concentrations (2.5 and 5 μM) in the reinvasion assay. Rel-
ative to Trx, the addition of Trx-RhopH3-C resulted in signiﬁcant inhibi-
tion of invasion at both 2.5 and 5.0 μM concentrations (Fig. 11D). Again,
the morphology and maturation of intra-erythrocytic parasites was not
affected by the presence of Trx-RhopH3-C (data not shown). Future
mapping studies of the band 3 binding sitewithin RhopH3-C is required
to identify high afﬁnity binding peptides for achievingmaximum inhibi-
tion of parasite invasion at high molar concentrations. Together, these
results identify the 5ABC region of RBC band 3 as the ﬁrst host receptor
for P. falciparum RhopH3 that mediates sialic acid independent invasion
of the malaria parasite in human red blood cells.
4. Discussion
Host receptors are thought to mediate initial attachment, reorienta-
tion, and penetration of merozoites in RBCs by regulating signaling of
speciﬁcally timed molecular steps of the invasion process. Over the
last three decades or so, signiﬁcant progress has been made towards
the functional identiﬁcation of Plasmodium proteins/ligands localized
to the merozoite surface, rhoptries, and micronemes that are known
to interact with host receptors during invasion [2,52]. In contrast, mo-
lecular understanding of the cognate receptors on host RBCs is relatively
limited. Naturally occurring mutations in human genes encoding RBC
membrane proteins have been informative [1]; however, these abnor-
mal RBCs are rare and their utility is limited to certain non-lethal hered-
itary genetic mutations. Targeted mutations of genes encoding RBC
membrane proteins in mice are technically challenging and time con-
suming. Moreover, this approach suffers from the criticism that the
receptor–ligand interaction(s) governing murine malaria parasites
might be different from P. falciparum. More recently, genetic manipula-
tion of erythroid progenitors has been used to interrogate novel host–
parasite interactions [28,53]. However, the potential of this approach
remains to be validated by the identiﬁcation of new ligand–receptor in-
teractions in future studies.
Using molecular and biochemical approaches, we previously identi-
ﬁed human RBC band 3 as an important host invasion receptor for
P. falciparum, binding to a parasite co-ligand complex containing
MSP119 (or MSP142) andMSP9 [29–31]. The core of the band 3 invasion
receptor includes two putative exofacial regions designated as 5C and
6A. The 5C peptide is part of the 5ABC region of band 3 as described pre-
viously [29]. In this study, using mono-speciﬁc anti-5C IgY and anti-6A
IgY antibodies, we demonstrate that 5C and 6A (or considerable parts
of these two regions) are indeed exposed on the normal human RBC
membrane. Since each 5C and 6A shares almost identical amino acid se-
quence between human and mouse (Fig. 1A), our failed attempts to
generate antibodies in mice against these two regions support the no-
tion that 5C and 6A peptides of band 3 are also exposed on the mouse
RBC surface. The ﬂow cytometry analysis of intact RBCs (Fig. 4) sug-
gested that the epitope(s) for anti-5C IgY is masked to some extent by
sialic acid residues on the normal human RBC surface, because the
antibody showed increased reactivity towards its epitope(s) on sialic
acid-depleted cells. It is unlikely that removing negatively charged sialic
acid residues from the cell surface would affect the normal folding of
RBC membrane proteins for the following two reasons: ﬁrst, in the
concentration-dependent invasion inhibition assay (Table 2),
preimmune IgY control samples for normal and Neu-treated RBCs
retained a similar level of parasitemia (5.6%–6.6%) in all IgY concen-
trations (0–200 μg/ml). Second, the binding of anti-6A IgY to its
epitope(s) on the intact RBC surface was not affected as judged by
the Bmax (Table 1). Native band 3 is folded in the RBC membrane
mainly as homo-dimers and tetramers, which are part of a larger
protein complex [54]. It is well established that GPA, heavily glyco-
sylated with sialic acid residues, interacts directly with band 3
Fig. 11. RhopH3 binds to RBCs and inhibits parasite invasion. (A) Untreated and enzyme-treated RBCswere incubatedwith Trx-RhopH3-C to allow binding. RBCswerewashed and bound
Trx-RhopH3-C was eluted with high NaCl. Eluted protein was analyzed by immunoblotting as described before. (B) Untreated and enzyme-treated human RBCs were used to prepare
ghosts for analysis by SDS-PAGE and Coomassie blue staining. (C) Western blotting of the material shown in panel B using an anti-band 3 antibody. The arrow indicates the position of
band 3 in untreated RBC ghosts. UT, untreated; C, chymotrypsin-treated; T, trypsin-treated; Neu, neuraminidase-treated; TT, triple-treated C + T + Neu. (D) Invasion inhibition assay
was carried out using the 3D7 strain of P. falciparum. The invasion assays were performed in triplicate at 2.5 and 5 μM concentrations due to the limitation of protein stability of recom-
binant Trx-RhopH3-Cunder these conditions. Trx proteinwasused as a negative control. (E) Proposedmodel ofmerozoite attachment to RBCs via interactions involving band3,MSP1, and
RhopH3.
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dimers and/or tetramers on the human RBC membrane contains 5C
that is fully exposed, whereas the remaining population has 5C
masked by sialic acid residues branched out from the surrounding
RBC membrane proteins (e.g., GPA). Interestingly, sialic acid content
of band 3 decreases during erythrocyte aging [58]. Moreover, it
has been hypothesized that oxidative stress may inﬂuence this
desialylation process. And while an altered glycosylation status of
band 3 did not show a signiﬁcant hematological effect in vivo, evi-
dence exists that glycosylation of band 3 is inhibitory towards oxida-
tive cross-linking [59,60].
This view is supported by the equilibrium binding parameters esti-
mated for anti-5C IgY in normal and Neu-treated RBC samples
(Table 1), in which the Kd remained relatively unchanged despite a
three-fold increase in the Bmax. These observations further support our
conclusion that the epitope(s) for mono-speciﬁc anti-5C IgY antibodyis exposed on the surface of normal RBCs. Our ﬁndings provide direct
evidence for the exofacial folding of 5C and 6A regions of band 3 in
the normal human RBCmembrane, thus lending support tomultiple to-
pology models for human RBC band 3 delineating the TM10–12 seg-
ments of the membrane domain [42–46].
Interestingly, the level of inhibition between the SAID and SAD inva-
sion phenotypes was much more signiﬁcant in the sialic acid-depleted
RBCs (Fig. 6C). We believe that this is mainly because the alternate
SAD invasion pathway utilizing RBC sialic acid residues has been practi-
cally eliminated by the Neu treatment of the cells. Under such condi-
tions, 3D7 and 7G8 strains would have no option to switch to the
alternate invasion pathway even in the presence of a pressuring effect
of anti-5C IgY, but continue to rely on the SAID invasion pathway. This
appears to be the case in the 3D7 and 7G8 strains because the
preimmune control samples showed no appreciable difference in the in-
vasion rate between normal and Neu-treated RBCs (Table 3). Moreover,
2869M. Baldwin et al. / Biochimica et Biophysica Acta 1843 (2014) 2855–2870the depletion of sialic acid residues increases the anti-5C IgY binding ca-
pacity of RBCs (Figs. 1, 2) and in turn provides better protection from in-
vasion by the SAID invasion phenotype (Fig. 6B). Taken together, sialic
acid-depleted RBCs provide a better model for determining the effect
of anti-band 3 antibodies on the SAID invasion phenotype and/or
pathway.
Themechanism bywhich P. falciparum invades human RBCs is more
complex thanwhat is known for other Plasmodium species, as two alter-
nate (SAD and SAID) invasion pathways have been implicated [6,7].
Moreover, these two broadly deﬁned invasion pathways seem to toler-
ate additional complexity, because there are further disparities within
each SAD and SAID invasion pathway characterized by the sensitivity
of the host invasion receptor function to proteolytic activities [5,13,
24]. In our invasion inhibition assays using the 3D7 strain, the mixture
of anti-5C and anti-6A IgY antibodies at a near saturating concentration
(200 μg/ml/each IgY) was able to block RBC invasion only by about 33%
and 65% in normal and sialic acid-depleted RBC samples, respectively
(Fig. 6). These results, togetherwith our invasion phenotype-speciﬁc in-
hibition study (Figs. 6 and 7), suggest that band 3 is a major host inva-
sion receptor in the SAID invasion pathway, but one or more host
receptor is also taking part in this pathway. Moreover, in sialic acid-
depleted RBC samples, the invasion rates for FCR3 and Dd2 strains
(SAD invasion phenotype) were reduced to 49% and 56%, respectively,
as compared to normal RBC samples, when preimmune IgY antibodies
(control) were present in the culture medium (Table 3). As neither
anti-5C nor anti-6A antibodies showed the invasion blocking effect at
a signiﬁcant level, our data suggest that the newly emerged invasion
phenotype does not rely on the host band 3 receptor during RBC inva-
sion. As pointed out above, another alternate host receptor could bepro-
viding a dominant interaction in order for FCR3 and Dd2 strains to
invade Neu-treated RBCs. It has been suggested that amolecular hierar-
chy of parasite ligands set by an unknown mechanism may determine
the dominant interaction(s) between a particular P. falciparum clone
and host RBCs during invasion [61].
The vast abundance and speciﬁcity of band 3 in the RBC membrane
suggest that this multi-transmembrane protein could serve as an
anchor for multiple malaria parasite proteins, facilitating a complex
merozoite invasion cascade in host RBCs. Band 3 exists in multiple sub-
populations in the host membrane, including mobile and anchored
dimers/tetramers as well as a tightly bound complex of band 3 with
glycophorin A [54]. These unique features of band 3 could be exploited
by the parasite to engage multiple ligands in a sequential manner to
facilitate invasion in RBCs. As part of our long term goal to map the
network of parasite invasion ligands that interact with a host band 3–
glycophorin A complex, we identiﬁed the carboxyl-terminus of
P. falciparum RhopH3 as the ligand interacting with the 5ABC region of
human band 3 (Figs. 8 and 9). A direct interaction between RhopH3-C
withMSP119was established (Fig. 9), consistentwith our previousﬁnd-
ings showing binding of theMSP1–MSP9 complexwith band 3 [31].We
also show that RhopH3-C binds to intact RBCs and recombinant
RhopH3-C inhibits parasite invasion in human RBCs (Fig. 11). Our re-
sults are consistent with previous ﬁndings that MSP1 participates in a
macro-protein complex of P. falciparum schizont-merozoite ligands
MSP-3, MSP-6, MSP-7, MSP-9, RhopH3, RhopH1/Clag, RAP-1, and RAP-
2, and two putative RAP domain containing proteins [32]. Recent
evidence showing that antibodies against RhopH3 inhibit merozoite in-
vasion [47] is consistent with our ﬁnding of a similar inhibitory effect of
recombinant RhopH3-C onmerozoite invasion in human RBCs (Fig. 11).
However, in contrast to the same study [47], our ﬁndings show that
RhopH3-C binding to RBCs is not affected in the trypsin-treated RBC
(Fig. 11). This observation could be explained due to the use of MBP-
RhopH3-C fusion in the previous study [47] and the Trx-RhopH3-C
fusion in this study. In fact, our attempts to use MBP-RhopH3-C failed
to ensure speciﬁcity of interaction with intact RBCs, presumably due
to the non-speciﬁc interaction of maltose binding protein (MBP) to re-
lated sugar moieties on the surface of human RBCs. Based on theseobservations, we infer that the use of MBP as an afﬁnity tag should be
avoided in designing binding assays of fusion proteins with intact
RBCs. Together, our ﬁndings provide the ﬁrst evidence that the 5ABC re-
gion of band 3 serves as a host receptor for P. falciparum RhopH3.
5. Conclusions
In conclusion, this study provides compelling biochemical evi-
dence that speciﬁc regions of loops 5 and 6 of human RBC band 3
are exposed and accessible to multiple ligands of P. falciparum
involved in the SAID invasion pathway. Given the known function
of host RBC sialoglycoproteins (GPA, GPB, GPC), complement
receptor-1, basigin, and putative receptors W, Y and Z as crucial inva-
sion phenotype-speciﬁc receptors [62], future identiﬁcation of domi-
nant host receptors for prevalent P. falciparum invasion phenotypes
will provide a better understanding of invasion phenotype-speciﬁc
host–parasite interactions and the extent of redundancy in the RBC in-
vasion mechanism. Further studies in this direction will facilitate and
contribute to the development of an effective malaria vaccine.
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